National Medicines Information Centre (NMIC)

Our latest Drug Safety Newsletter offers healthcare professionals essential information on safe and effective use of medicines. It includes information on: → Finasteride and Dutasteride: Outcome of EU review on risk of suicidal ideation → Bilastine (oral): New warning about risk of QT prolongation/Torsades de Pointes → Azathioprine: Updated hepatotoxicity warning → Mesalazine: New warning about idiopathic intracranial hypertension Download the newsletter: hpra.ie/safety-informa…

The May edition of the NMIC newsletter Therapeutics Today is now available at nmiccomms.newsweaver.com/1op99me28j/1le…

The April edition of the NMIC newsletter Therapeutics Today is now available at nmiccomms.newsweaver.com/1op99me28j/w5m…

Check out the March edition of the NMIC newsletter Therapeutics Today at nmiccomms.newsweaver.com/1op99me28j/12e…

The January 2025 edition of the NMIC newsletter Therapeutics Today is out now! Check it out at: nmiccomms.newsweaver.com/1op99me28j/at9…

The December edition of the NMIC newsletter Therapeutics Today is now available at nmiccomms.newsweaver.com/14ig36yfht/18w…

Our latest Drug Safety Newsletter provides healthcare professionals with information for using medicines safely and effectively. This edition includes: → Updates on pregnancy outcomes with fluconazole and advice for women who could become pregnant → EU review begins on the link between suicidal thoughts and behaviours with finasteride and dutasteride → Higher risk of atrial fibrillation in patients with heart disease or risk factors when using Omega-3-acid ethyl esters Download the newsletter: hpra.ie/homepage/about…

The November edition of the NMIC newsletter Therapeutics Today is available at nmiccomms.newsweaver.com/14ig36yfht/2sl…

The October edition of the NMIC newsletter ‘Therapeutics Today’ is now available at nmiccomms.newsweaver.com/14ig36yfht/u8p…

Updated guidance from @IMSN_ie & @ParkinsonsIre of the importance of timing of medication for patients with Parkinson’s imsn.ie/wp-content/upl… @roinnslainte @theHPAI @IrishPharmacy @ParkinsonDotOrg @moversand6 @CcoHse @PFPS_Ireland

The IIOP are delighted to have collaborated with the NCCP on the creation of this important resource for pharmacists caring for patients with cancer The Hub is now live on the IIOP website➡️iiop.ie/content/cancer…   #WorldPharmacistDay #CancerCareHub @hseNCCP @michelleodris

Our latest Drug Safety Newsletter offers valuable updates for healthcare professionals aimed at promoting the safe and effective use of medications. This edition features articles on: → The inadvertent ocular exposure to chlorhexidine during surgical site preparation → The availability of educational materials for valproate and topiramate medicines → Highlighting the importance of reporting suspected adverse reactions Download the newsletter: hpra.ie/homepage/about…

The September edition of the NMIC newsletter Therapeutics Today is now available at nmiccomms.newsweaver.com/14ig36yfht/1lg…

The August edition of the NMIC newsletter Therapeutics Today is now available at nmiccomms.newsweaver.com/14ig36yfht/ml9…

The June edition of the NMIC newsletter Therapeutics Today #NMICTT is now available at nmiccomms.newsweaver.com/14ig36yfht/wmk…

Check out our most recent NMIC Bulletin #NMICbulletin ‘Use of medicines with anticholinergic activity’, Vol 30, No.3 May 2024 at nmiccomms.newsweaver.com/hb4gz6mh51/tmv…

The May edition of the NMIC newsletter Therapeutics Today #NMICTT is now available athttps://nmiccomms.newsweaver.com/14ig36yfht/1x6fqz7xdhp. Check it out for information on risk of adverse events after initiation of AHT in older people; risk of serious falls and opioids.

Check out on most recent NMIC bulletin #NMICbulletin ‘Prostate Cancer Survivorship and Androgen Deprivation Therapy’ Vol 30, No.2. (April 2024) at nmiccomms.newsweaver.com/hb4gz6mh51/w5l…

Our latest Drug Safety Newsletter provides updates for healthcare professionals to support the safe and appropriate use of these medicines: → Valproate (Epilim): New precautionary measures for fathers taking the medicine in the three months before conception → NSAIDs: Updated recommendations on use during pregnancy → Cystic Fibrosis transmembrane conductance regulators: New warning on the risk of depression with specific medicines in this category Download the newsletter: hpra.ie/homepage/about…

Check out our most recent NMIC Bulletin on Breast cancer and adjuvant endocrine therapy,  March 2024, Vol 30, No 1,  at nmiccomms.newsweaver.com/hb4gz6mh51/1vv…